Your browser doesn't support javascript.
loading
Years of life lost due to cancer in the United Kingdom from 1988 to 2017.
Ahmad, Amar S; Offman, Judith; Delon, Christine; North, Bernard V; Shelton, Jon; Sasieni, Peter D.
Afiliação
  • Ahmad AS; Cancer Intelligence, Cancer Research UK, London, UK.
  • Offman J; Cancer Prevention Group, School of Cancer and Pharmaceutical Sciences, King's College London, London, UK. j.m.offman@qmul.ac.uk.
  • Delon C; Wolfson Institute of Population Health, Queen Mary University of London, London, UK. j.m.offman@qmul.ac.uk.
  • North BV; Cancer Intelligence, Cancer Research UK, London, UK.
  • Shelton J; Cancer Research UK and King's College London Cancer Prevention Trials Unit, Cancer Prevention Group, School of Cancer and Pharmaceutical Sciences, King's College London, London, UK.
  • Sasieni PD; Cancer Intelligence, Cancer Research UK, London, UK.
Br J Cancer ; 129(10): 1558-1568, 2023 11.
Article em En | MEDLINE | ID: mdl-37726479
ABSTRACT

BACKGROUND:

We investigated the application of years of life lost (YLL) in routine cancer statistics using cancer mortality data from 1988 to 2017.

METHODS:

Cancer mortality data for 17 cancers and all cancers in the UK from 1988 to 2017 were provided by the UK Association of Cancer Registries by sex, 5-year age group, and year. YLL, age-standardised YLL rate (ASYR) and age-standardised mortality rate (ASMR) were estimated.

RESULTS:

The annual average YLL due to cancer, in the time periods 1988-1992 and 2013-2017, were about 2.2 and 2.3 million years, corresponding to 4510 and 3823 ASYR per 100,000 years, respectively. During 2013-2017, the largest number of YLL occurred in lung, bowel and breast cancer. YLL by age groups for all cancers showed a peak between 60-64 and 75-79. The relative contributions to incidence, mortality, and YLL differ between cancers. For instance, pancreas (in women and men) made up a smaller proportion of incidence (3%) but bigger proportion of mortality (6 and 5%) and YLL (5 and 6%), whereas prostate cancer (26% of incidence) contributed 13% mortality and 9% YLL.

CONCLUSION:

YLL is a useful measure of the impact different cancers have on society and puts a higher weight on cancer deaths in younger individuals.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata / Neoplasias da Mama Limite: Humans / Male País/Região como assunto: Europa Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata / Neoplasias da Mama Limite: Humans / Male País/Região como assunto: Europa Idioma: En Ano de publicação: 2023 Tipo de documento: Article